CT colonography can screen for both colorectal cancer and osteoporosis reliably at minimal additional cost and time, according to a study presented Tuesday at the RSNA meeting.
CT colonography can screen for both colorectal cancer and osteoporosis reliably at minimal additional cost and time, according to a study presented Tuesday at the RSNA meeting.
Because the images are cross-sections of the entire body, CT colonography scans can also be constructed into a three-dimensional model of the spine, which can be used to measure bone mineral density, according to lead author Rizwan Aslam, an assistant clinical professor of radiology at the University of California, San Francisco. This information can then be used to determine the risk or presence of osteoporosis.
"We wanted to look at the ability of CT to not only screen for colon cancer but also allow identification of patients with osteoporosis and we thought we could crack both of them with this test," Aslam said.
A study at San Francisco VA Hospital compared the results of CT colonography scans with those of dual x-ray absorptiometry examinations, the standard imaging technique used to score bone mineral density and diagnose osteoporosis. The study compared DXA scores with CT colonography results in 30 men and five women ranging in age from 54 to 79.
Results showed excellent agreement between the DXA bone mineral density scores and the data obtained through the CT colonography study. The ability to perform colonography and bone densitometry simultaneously could be especially valuable because colon cancer and osteoporosis both affect adults over the age of 50. Doubling up the exams also means avoiding radiation exposure from a second scan.
"Virtual colonoscopy can successfully evaluate patients for osteoporosis, and colonoscopy provides valuable information on osteoporosis risk with no additional radiation or cost," Aslam said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.